Suggestions
Gregory Ferenstein
Mental Health Innovation & Psychedelics Consulting
Gregory Ferenstein is the Chief Executive Officer at Frederick Research, a position he has held since 2020.1 He is a multifaceted professional with experience in research, journalism, and public affairs.
Career Highlights
- Research Fellow at Reason Foundation (June 2023 - Present)1
- Editor at Ferenstein Wire (March 2015 - 2016)1
- Writer for various publications including TechCrunch (2012-2014), Mashable (2010-2011), and Fast Company (2011)1
- Researcher at the University of California, Irvine (2006-2010)1
Expertise
Ferenstein specializes in technology, business, and politics.4 He is particularly focused on mental health innovation, psychedelic policy, and their impact on economic recovery and upward mobility.5 As a senior fellow in drug policy at Reason Foundation, he has written extensively on psychedelics legalization and policy across various states.2
Education and Skills
He holds a Master's Degree in Mathematical Behavioral Sciences.4 Ferenstein is also known for designing college curricula to improve teamwork, communication, and technological skills.4
Public Speaking and Media Presence
Ferenstein has given talks at prominent venues such as Google, discussing Silicon Valley's unique political and moral values.3 He has authored articles for Business Insider4 and has been featured in publications like The New York Times, Washington Post, and The Guardian.6
Gregory Ferenstein's work spans across research, policy analysis, and advocacy, with a particular focus on innovative approaches to mental health and drug policy.
Highlights
I created my own chatbot to talk to during trips using OpenAI’s API. I also had a therapist, i found GPT-4 more available and better at asking the right questions. My chatbot is my second choice in case a friend isn’t around.
I am curious if this is an FCC violation. @BrendanCarrFCC has promised to look into censorship rules on these platforms. Meta is shutting down accounts that merely report news on psychedelics.